← Evidence map

ArticleAllergy2026

Comprehensive Analysis of Type 2 Innate Lymphoid Cell (ILC2) Heterogeneity and Identification of CD81 as a Marker for Pathogenic IL-13

Mai Nishimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2026

this papercites it

Comprehensive Analysis of Type 2 Innate Lymphoid Cell (ILC2) Heterogeneity and Identification of CD81 as a Marker for Pathogenic IL-13 | OpenQuestion